227 related articles for article (PubMed ID: 29573126)
1. The influence of thyroid function on the coagulation system and its clinical consequences.
Elbers LPB; Fliers E; Cannegieter SC
J Thromb Haemost; 2018 Apr; 16(4):634-645. PubMed ID: 29573126
[TBL] [Abstract][Full Text] [Related]
2. Thyroid dysfunction and hemostasis: an issue still unresolved.
Franchini M; Montagnana M; Manzato F; Vescovi PP
Semin Thromb Hemost; 2009 Apr; 35(3):288-94. PubMed ID: 19452404
[TBL] [Abstract][Full Text] [Related]
3. Hemostatic changes in thyroid diseases: haemostasis and thrombosis.
Franchini M
Hematology; 2006 Jun; 11(3):203-8. PubMed ID: 17325963
[TBL] [Abstract][Full Text] [Related]
4. [Atrial fibrillation and thyroid gland].
Bindi M; Pinelli M; Rosada J; Castiglioni M
Recenti Prog Med; 2005 Nov; 96(11):548-51. PubMed ID: 16499161
[TBL] [Abstract][Full Text] [Related]
5. [Disorders of hemostasis in dysthyroidism].
Klein M; Barbé F; Kaminsky P; Duc M
Pathol Biol (Paris); 1993 Mar; 41(3):268-75. PubMed ID: 8332397
[TBL] [Abstract][Full Text] [Related]
6. Effects of Thyroid Function on Hemostasis, Coagulation, and Fibrinolysis: A Mendelian Randomization Study.
Ellervik C; Mora S; Kuś A; Åsvold B; Marouli E; Deloukas P; Sterenborg RBTM; Teumer A; Burgess S; Sabater-Lleal M; Huffman J; Johnson AD; Trégouet DA; Smith NL; Medici M; DeVries PS; Chasman DI; Kjaergaard AD
Thyroid; 2021 Sep; 31(9):1305-1315. PubMed ID: 34210154
[No Abstract] [Full Text] [Related]
7. Effects of thyroid hormone on the cardiovascular system.
Fazio S; Palmieri EA; Lombardi G; Biondi B
Recent Prog Horm Res; 2004; 59():31-50. PubMed ID: 14749496
[TBL] [Abstract][Full Text] [Related]
8. The alteration of coagulation in patients with thyroid dysfunction.
Akinci B; Comlekci A; Ozcan MA
Recent Pat Endocr Metab Immune Drug Discov; 2011 Jan; 5(1):50-7. PubMed ID: 22074577
[TBL] [Abstract][Full Text] [Related]
9. Prothrombotic changes due to an increase in thyroid hormone levels.
Horacek J; Maly J; Svilias I; Smolej L; Cepkova J; Vizda J; Sadilek P; Fatorova I; Zak P
Eur J Endocrinol; 2015 May; 172(5):537-42. PubMed ID: 25637077
[TBL] [Abstract][Full Text] [Related]
10. History of thyroid disorders in relation to clinical outcomes in atrial fibrillation.
Bruere H; Fauchier L; Bernard Brunet A; Pierre B; Simeon E; Babuty D; Clementy N
Am J Med; 2015 Jan; 128(1):30-7. PubMed ID: 25058863
[TBL] [Abstract][Full Text] [Related]
11. [Thyroid and hemostasis].
Franchini M
Recenti Prog Med; 2006 May; 97(5):267-71. PubMed ID: 16838559
[TBL] [Abstract][Full Text] [Related]
12. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.
Erem C; Ucuncu O; Yilmaz M; Kocak M; Nuhoglu I; Ersoz HO
Endocrine; 2009 Feb; 35(1):75-80. PubMed ID: 18958631
[TBL] [Abstract][Full Text] [Related]
13. Association between thyroid dysfunction and venous thromboembolism in the elderly: a prospective cohort study.
Segna D; Méan M; Limacher A; Baumgartner C; Blum MR; Beer JH; Kucher N; Righini M; Matter CM; Frauchiger B; Cornuz J; Aschwanden M; Banyai M; Osterwalder J; Husmann M; Egloff M; Staub D; Lämmle B; Angelillo-Scherrer A; Aujesky D; Rodondi N
J Thromb Haemost; 2016 Apr; 14(4):685-94. PubMed ID: 26816339
[TBL] [Abstract][Full Text] [Related]
14. COPD and thyroid dysfunctions.
Terzano C; Romani S; Paone G; Conti V; Oriolo F
Lung; 2014 Feb; 192(1):103-9. PubMed ID: 24281671
[TBL] [Abstract][Full Text] [Related]
15. Thyroid status, cardiovascular risk, and mortality in older adults.
Cappola AR; Fried LP; Arnold AM; Danese MD; Kuller LH; Burke GL; Tracy RP; Ladenson PW
JAMA; 2006 Mar; 295(9):1033-41. PubMed ID: 16507804
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the respective influence of thyroid hormones and TSH on blood coagulation parameters after total thyroidectomy.
Yango J; Alexopoulou O; Eeckhoudt S; Hermans C; Daumerie C
Eur J Endocrinol; 2011 Apr; 164(4):599-603. PubMed ID: 21257724
[TBL] [Abstract][Full Text] [Related]
17. Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover study.
Van Zaane B; Squizzato A; Debeij J; Dekkers OM; Meijers JC; Van Zanten AP; Büller HR; Gerdes VE; Cannegieter SC; Brandjes DP
J Thromb Haemost; 2011 Sep; 9(9):1816-24. PubMed ID: 21729238
[TBL] [Abstract][Full Text] [Related]
18. Thyroid diseases and cerebrovascular disease.
Squizzato A; Gerdes VE; Brandjes DP; Büller HR; Stam J
Stroke; 2005 Oct; 36(10):2302-10. PubMed ID: 16179578
[TBL] [Abstract][Full Text] [Related]
19. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
20. Thyroid disorders and hypercoagulability.
Erem C
Semin Thromb Hemost; 2011 Feb; 37(1):17-26. PubMed ID: 21249601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
